Dr. Francisco Ayala de la Peña is a medical oncologist associated with Hospital General Universitario Gregorio Marañón in Madrid, Spain. The hospital identifies him as head of its Medical Oncology Department and as a contributor to oncology education and research. His professional work is connected with the multidisciplinary management of cancer and the organization of specialist oncology services.

Medical Oncology and Clinical Practice

Medical oncology focuses on the systemic treatment of cancer. Depending on the diagnosis, treatment may include chemotherapy, hormone therapy, immunotherapy, targeted medicines, and other therapies selected according to tumor characteristics and clinical circumstances.

As head of the Medical Oncology Department, Dr. Ayala is associated with a service that organizes care according to cancer type. The hospital lists specialist units for genitourinary cancers, breast cancer and melanoma, digestive tumors, and thoracic tumors, head and neck cancers, and sarcomas.

This structure supports referral to clinicians with experience in particular tumor groups and facilitates collaboration between medical oncology and other specialties.

Personalized Cancer Treatment

Cancer treatment planning requires review of pathology, imaging, disease stage, previous therapies, molecular test results, and the patient's overall health. Medical oncologists assess the potential benefits and risks of available treatment options and discuss the treatment pathway with the patient.

For some cancers, chemotherapy may be used before surgery to reduce tumor size or after surgery to reduce recurrence risk. Targeted therapies and immunotherapies may be appropriate for selected patients based on tumor biomarkers and established clinical indications.

No treatment is appropriate for every patient. Decisions are individualized and may involve discussion with surgical oncology, radiation oncology, radiology, pathology, and supportive care teams.

Department Leadership and Organization

The hospital's official oncology page identifies Dr. Ayala as head of the Medical Oncology service. The department's structure includes specialist units and a dedicated oncology clinical research unit. The hospital describes clinical, teaching, and research activities as integrated parts of its oncology service.

The department also contributes to specialist education. The official information describes supervised clinical rotations and oncology training for medical students and doctors undertaking specialist training.

Clinical Research and Trials

Clinical oncology research evaluates cancer treatments and methods of improving patient care. Trials may study new medicines, treatment combinations, supportive care, or diagnostic approaches.

The hospital's oncology research unit was established in 2010 under the direction of Prof. Miguel Martín, and the service describes multidisciplinary clinical and translational research as part of its work.

Eligibility for a clinical trial depends on the cancer diagnosis, stage, previous treatment, laboratory and molecular findings, and recruitment status. Patients should obtain confirmation from the hospital's research team before making travel or treatment arrangements.

International Patient Information

Patients seeking an oncology consultation in Madrid should prepare pathology reports, biopsy results, imaging studies, previous treatment summaries, molecular testing, medication lists, and information about allergies and other medical conditions.

These records help the oncology team understand the diagnosis and assess whether further investigations, a second opinion, or a treatment consultation is appropriate.

Dr. Francisco Ayala de la Peña is listed as head of Medical Oncology at Hospital General Universitario Gregorio Marañón. His profile is relevant to patients researching medical oncology services and coordinated cancer care in Madrid. Confirm current appointment availability directly with the hospital.